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Background: Variability in reported histopathology parameters in operated periampullary adenocarcinomas may
affect the prognostic weight of the parameters. Standardized axial sectioning produces a higher incidence of
involved margins and also seems to produce a lower relative incidence of pancreatic compared with distal bile
duct origin and a higher incidence of involved lymph nodes, compared with non-standardized procedure. The aims
of this study were to 1) assess how a previously not described standardized pathology procedure, with longitudinal
sectioning along the distal bile duct, affects reported tumour origin, margin status and involved lymph nodes,
compared with non-standardized procedure, 2) assess if re-evaluation of microscopic slides affects the prognostic
value of margin status and 3) compare the results of this standardized procedure with reported results of other
standardized and non-standardized procedures.
Methods: One hundred seventy-five consecutive pancreaticoduodenectomy specimens with primary adenocarcinomas,
operated during 2001 – 2011 at the University hospitals of Lund and Malmö, Sweden, were re-evaluated histologically,
and parameters relevant for classification and prognosis were assessed, with 1 mm as a threshold for involved or
uninvolved margins. Follow-up lasted until 31 December 2013. Five-year overall survival (OS) and hazard ratios (HR) were
calculated for the margin status stated in the original reports and margin status after re-evaluation.
Results: Compared with non-standardized cases (n = 129), standardized cases (n = 46) had more involved lymph nodes
in the specimens (median 3 vs 1), a higher fraction of distal bile duct origin (39% vs 21%) and a higher fraction of
involved margins (74% vs 47%). The prognostic value of uninvolved margins increased by re-evaluation of slides
(p < 0.001) and the adjusted HR for involved margins increased from 1.6 (95% CI 1.1 - 2.4) to 3.3 (95% CI 1.5 – 7.0).
Uninvolved margins remained a significant predictor of OS in adjusted analysis.
Conclusions: Both the method of sectioning the specimen and the microscopic assessment affect prognostic
pathology parameters significantly. The results of the herein described standardized method are similar to the
results of other standardized procedures. The 1-mm threshold for involved margins in pancreaticoduodenectomies
is relevant for OS, and margin status is an independent prognostic parameter.
Virtual slides: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1056639379120615
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Pathology guidelines that change the incidence of histo-
pathology parameters are clinically relevant since the
parameters carry prognostic information. Guidelines on
gross examination and sectioning of pancreaticoduode-
nectomy (PD) specimens have changed during the last
years, after the introduction of the Leeds pathology proto-
col (LEEPP) [1]. This standardized procedure raised the
incidence of involved margins (R1) and involved lymph
nodes (N1), and also decreased pancreatic origin and in-
creased distal bile duct origin [2,3] compared to large series
using non-standardized procedures [4-10].
Proportions of tumour origin vary greatly between dif-
ferent series of operated periampullary adenocarcinomas
and it is not known which proportions most accurately
reflect the biology of the tumours, or are most clinically
relevant. It is however evident that a meticulous path-
ology examination improves the quality of the pathology
report for these cancer forms by producing a higher in-
cidence of N1 and R1 [2]. A high proportion of R1 also
seems to correlate to a low relative incidence of pancre-
atic origin, suggesting that a more thorough examination
decreases the relative incidence of pancreatic origin [11].
So far, the reported increase of R1 and decrease in pan-
creatic origin in the LEEPP-series has been attributed to
this particular slicing method. It is however not clear to
what extent this change is due to the method or to the
interest and dedication of the pathologist.
Here, we present the results of a different standardized
protocol (SP), in which the pathologist gains access to
the full length of the common bile duct through a longi-
tudinal opening via the posterior margin of the PD-
specimen, and only standard size blocks are made. It has
been stated that this method is inferior to the LEEPP,
due to its limited value for assessing tumour origin and
resection margins [1]. This method has however not
been studied in a standardized setting before.
Methods
Data collection and patient characteristics
The study cohort is a retrospective consecutive series of
175 PD-specimens with primary adenocarcinomas surgi-
cally treated at the University hospitals of Lund and
Malmö, Sweden, from January 1 2001 until December
31 2011. Data on survival were gathered from the Swedish
National Civil Register. Follow-up started at the date of
surgery and ended at death or at December 31 2013,
whichever came first.
Data on margin status was collected from the original
pathology reports, as were data on age at surgery, date
of surgery, sex, and whether the specimen was handled
according to the SP or not. Data was also gathered on
the origin of lymph nodes submitted in separate con-
tainers. After information was given on how and fromwhere the surgeons harvested lymph nodes submitted in
separate containers, positions 6, 8, 12, 13, 14 and 17
were classified as originating from the specimen, and
other positions including 9 and 16 were classified as not
originating from the specimen.
Of the 175 PDs, 46 (26%) were examined and sec-
tioned according to our SP by one pathologist (JE) and
129 (74%) were examined and sectioned by several pa-
thologists according to personal choice (non-standardized
protocol, NSP).
Ethical permission was obtained from the Ethics Com-
mittee at Lund University.
Sectioning of the specimens, standardized protocol
This method is, by opening the PD-specimen along the
bile duct, similar to one of the methods earlier described
by the Royal College of Pathologists [12] but performed
in a standardized manner and without opening the pan-
creatic duct.
The specimens were handled after fixation in formalin
(Figure 1). Margins were stained in different colours;
one for the pancreatic transection margin, one for the
margin towards the superior mesenteric vein (SMV),
one for the margin towards the superior mesenteric ar-
tery (SMA), one for the anterior surface and one for the
posterior margin. The specimens were accessed through
a longitudinal opening of the common bile duct at the
posterior margin, from the most proximal part of the
bile duct through the papilla of Vater. In the same plane
the section was deepened through the common bile duct
and into the pancreatic parenchyme. This produced a
book-like opening that visualized the whole length of the
common bile duct, the ampulla and adjacent pancreatic
parenchyme as well as parts of the posterior margin and
parts of the SMV-margin. Several standard size blocks
were sampled from the ampulla with adjacent duodenal
mucosa, pancreatic parenchyme and anterior and poster-
ior margins. The bile duct was sampled longitudinally,
with adjacent pancreatic parenchyme, posterior margin
and SMV-margin. Additional standard size blocks were
sampled from the SMA-margin, from all visible or palp-
able lymph nodes in the specimen and from additional
areas with possible tumour growth. En face sections
were made from the pancreatic, bile duct, pyloric and
duodenal transection margins.
Standardized protocol vs non-standardized protocol
Re-evaluations of slides
All haematoxylin & eosin stained slides from all cases
were revised by one pathologist (JE), blinded to the ori-
ginal report and outcome. Other stains were not revised
or used for the assessment of any parameter. Data were
gathered on tumour origin, size and grade, perineural in-
vasion, lymphatic vessel and blood vessel invasion, invasion
Figure 1 Accessing a pancreaticoduodenectomy specimen through the bile duct. (A) Anterior view of a painted pancreaticoduodenectomy
specimen. Posterior – black, anterior – blue, pancreatic transection margin – yellow, SMV-margin - red and SMA-margin - green. A probe is
inserted in the lumen of the bile duct. (B) posterior view, (C) posterior view with the bile duct opened longitudinally, and (D) the pancreatic
parenchyme accessed through the bile duct, visualizing the ampulla, the bile duct and parts of the pancreatic parenchyme, as well as parts of
the margins.
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lymph nodes found by the pathologist in the specimen,
number of lymph nodes and involved lymph nodes har-
vested from the specimen by the surgeon and submitted in
separate containers, number of lymph nodes and involved
lymph nodes in separate containers originating from other
areas, N-stage, T-stage and margin status.
Decision on tumour origin was based on the anatomical
centre of the tumour, with the aid of preinvasive precursor
lesions or multifocality, if present. A tumour in the duo-
denal mucosa with intestinal morphology that involved theampulla in the periphery was considered to be of duodenal
origin. A similar tumour with the ampulla in the centre
was considered to be of ampullary origin. A tumour along
the bile duct that involved the ampulla was considered to
be of bile duct origin if the ampulla was in the periphery of
the tumour, but of ampullary origin if the ampulla was in
the centre. Multifocal tumour growth or multifocal prema-
lignant changes in the pancreatic parenchyme in the
absence of evidence of other tumour origin was consid-
ered as a sign of pancreatic origin. In addition to tumour
origin the distinction between intestinal morphology and
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carcinomas using morphological criteria [13].
For the assessment of tumour grade, only the poorest
degree of differentiation was recorded.
Margin status was denoted as R1 if cancer was present
less than 1 mm from any margin except for the duo-
denal serosa, as R0 if the shortest distance exceeded
1 mm, and as unknown (Rx) if any margin, except the
duodenal serosa close to the cancer, was insufficiently
sampled. If a margin was considered sufficiently sampled
or not differed by the location of the tumour. In addition
to pancreatic and distal bile duct transection margins, an
ampullary carcinoma needed at least one standard size
block showing the relation to the anterior surface, adja-
cent to the duodenal wall, two showing the relation to
the posterior surface adjacent to the duodenal wall, one
from the SMA-margin and one from the SMV-margin,
in order to be considered sufficiently sampled regarding
margins. Carcinomas of pancreatic or distal bile duct
origin needed, in addition to pancreatic and distal bile
duct transection margins, at least two blocks showing
the relation to the posterior margin, one from the SMA-
margin, one from the SMV-margin and one from the an-
terior margin. For duodenal origin, one block each from
the posterior and anterior margins adjacent to the duo-
denal wall was considered sufficient. A case could be
considered as R1 in an unspecified margin even if other
margins were insufficiently sampled.
For sampling of lymph nodes in the specimen, the full
surface around the specimens was searched manually
and also visually after sectioning in intervals of approxi-
mately 3 mm.
Statistical analysis
The Chi-square test and Fisher’s Exact test were used to
analyse differences in the distribution of histopatho-
logical factors in relation to use of standardized vs non-
standardized protocol, and according to tumour loca-
tion. Kaplan-Meier analysis and log rank test were used
to illustrate differences in 5-year overall survival (OS) in
strata according to margin status. Cox regression models
were used to calculate hazard ratios (HR) for the impact
of histopathology parameters on 5-year OS, in univariable
and multivariable analysis, adjusted for age, sex, tumour
morphology, tumour size, tumour grade, T-stage, N-stage,
margin status, perineural invasion, growth in peripan-
creatic fat, invasion of lymphatic vessels and invasion
of blood vessels. Cases who died within 1 month from
surgery (n = 2) or were lost to follow up (n = 1) were ex-
cluded from the survival analyses.
All tests were two-sided and a p-value <0.05 was con-
sidered statistically significant. All statistical analyses were
performed using IBM SPSS Statistics version 20.0 (SPSS
Inc., Chicago, IL, USA).Results
The annual PD-rate increased during the study period,
with 35 and 29 cases operated in 2010 and 2011, re-
spectively, compared to a median of 13 per year (range
8–19) during 2001–2009. Forty-two of the 46 SP-cases
were diagnosed during 2010 – 2011, which coincided
with an increased number of lymph nodes sent for ana-
lysis in separate containers; median 1 (interquartile
range, IQR 0 – 2) during 2001 – 2009 and median 7
(IQR 3.25 – 10) during 2010 – 2011.
Median 5-year OS was 30.4 months in the full cohort of
all 172 SP- and NSP-cases, 35.0 months in the SP-group
and 29.7 months in the NSP-group. In the SP-group of 46
cases, 27 died during follow up and 19 were censored at
December 31 2013. Out of the 129 NSP-cases, 3 were ex-
cluded from the survival analysis, but included in all other
analyses. Of the remaining 126 cases, 88 died during follow
up and 38 were censored at December 31 2013.
Differences in the distribution of histopathological
parameters between SP-cases and NSP-cases
As shown in Table 1, there were several significant dif-
ferences in the distribution of histopathological parame-
ters between the re-evaluated NSP- and SP-materials.
Tumour origin differed between the SP-group and the
NSP-group (p = 0.040), with a higher proportion of distal
bile duct origin (39% vs 21%) and a lower proportion of
ampullary origin (26% vs 45%) in the former.
There was no significant difference between the SP-
group and the NSP-group regarding the number of lymph
nodes found by the pathologist in the PD-specimens, but
the number of lymph nodes harvested from the specimen
by the surgeon, as well as the total number of lymph
nodes originating from the PD-specimens, was signifi-
cantly higher in the SP-group compared with the NSP-
group (p < 0.001 for both).
The number of involved lymph nodes in the PD-
specimens was also significantly higher in the SP-group
as compared with the NSP-group (p = 0.001), and the
number of involved lymph nodes from the PD-specimens
submitted in separate containers and total number of in-
volved lymph nodes originating from the specimens dif-
fered significantly. The proportion of cases with involved
lymph nodes (N1-N2) did not differ significantly between
the SP-group and NSP-group.
Since the increase in the number of lymph nodes har-
vested from the specimen by the surgeon occurred in
2009, a separate analysis on lymph node-variables was
performed for the last 2.5 years of the study period
(July 2009 – 2011). This revealed a significant difference
between the SP-group (n = 44) and the NSP-group (n = 31)
in the number of involved lymph nodes found in the PD-
specimens by the pathologist (median 2.5 vs 1, p = 0.046).
There were however no significant differences in the total
Table 1 Standardized vs non-standardized protocol: Characteristics of 175 re-evaluated periampullary adenocarcinomas
NSP SP p-value All
(n = 129) (n = 46) (n = 175)
Tumour origin 0.040
Duodenum 9 (7%) 5 (11%) 14 (8%)
Ampulla, both types 58 (45%) 12 (26%) 70 (40%)
Distal Bile Duct 27 (21%) 18 (39%) 45 (26%)
Pancreas 35 (27%) 11 (24%) 46 (26%)
Tumour size, mm
M (IQR) 30 (20–35) 30 (25–40) 0.649 30 (21–35)
Larger than 20 mm 92 (71%) 42 (91%) 0.008 134 (77%)
Differentiation, poor 70 (54%) 31 (67%) 0.164 101 (58%)
Lymph nodes
In PD specimen, M (IQR) 6 (3–10) 9 (7–13) 0.102 7 (4–10)
From PD specimens, M (IQR) 1 (0–2) 7 (3–9) <0.001 2 (0–5)
Total PD specimen, M (IQR) 8 (5–12) 16 (12–19) <0.001 11 (6–15)
≥10 lymph nodes PD specimen, n (%) 58 (45%) 40 (87%) <0.001 98 (56%)
Other local lymph nodes, M (IQR) 0 (0–1) 0 (0–1) 0.400 0 (0–1)
Total, all lymph nodes, M (IQR) 9 (5–13) 16 (13–20) <0.001 11 (6–16)
Involved lymph nodes
In PD specimen, M (IQR) 1 (0–2) 3 (0–4) 0.001 1 (0–3)
From PD specimen, M (IQR) 0 (0–0) 0 (0–1) 0.024 0 (0–0)
Total PD specimen, M (IQR) 1 (0–2) 3 (0–4) 0.023 1 (0–3)
Other local, M (IQR) 0 (0–0) 0 (0–0) 0.017 0 (0–0)
Total, all involved lymph nodes, M (IQR) 1 (0–2) 3 (0–4) 0.015 1 (0–3)
N-stage, pN1 (for duodenum pN1-N2) 74 (57%) 33 (72%) 0.113 107 (61%)
Margin involvement <0.001
R1 60 (47%) 34 (74%) 94 (54%)
Rx (uncertain/unassessable) 56 (43%) 0 (0%) 56 (32%)
R0 13 (10%) 12 (26%) 25 (14%)
Perineural infiltration 71 (55%) 34 (74%) 0.035 105 (60%)
Infiltration in lymph vessels 79 (61%) 32 (70%) 0.374 111 (63%)
Infiltration in blood vessels 38 (29%) 4 (9%) 0.004 42 (24%)
Infiltration in peripancreatic fat 71 (55%) 36 (78%) 0.008 107 (61%)
T-stage 0.074
pT1 8 (6%) 0 (0%) 8 (4%)
pT2 21 (17%) 3 (6%) 24 (14%)
pT3 70 (54%) 33 (72%) 103 (59%)
pT4 30 (23%) 10 (22%) 40 (23%)
Blocks from PD-specimen
Regular blocks, Median (IQR) 15 (12–22) 23 (20–27) 0.001
Mean (min - max) 17 (6–48) 24 (14–36)
Large blocks, Median (IQR) 0 (0–2) 0 (0–0) <0.001
Mean (min - max) 1 (0–8) 0 (0–0)
SP, standardized procedure. NSP, non-standardized procedure. PD, pancreatoduodenectomy. M, median. IQR, interquartile range. SMA, superior mesenteric artery.
SMV, superior mesenteric vein. For margin involvement p-values were calculated R1 vs R0 and Rx. Bold text indicates p < 0.05.
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12, p = 0.601), fraction of cases with 10 or more lymph
nodes (89% vs 74%, p = 0.128) or fraction of cases with in-
volved lymph nodes (71% vs 65%, p = 0.622).
As further shown in Table 1, there was a significantly
larger proportion of R1 cases (p = 0.002), tumours lar-
ger than 20 mm (p = 0.008), perineural tumour growth
(p = 0.035) and infiltration of peripancreatic fat (p = 0.002)
in the SP-group compared with the NSP-group. In con-
trast, infiltration of blood vessels was more often found in
the NSP-group (p = 0.004).
We also examined the involvement of different resection
margins by tumour type (Table 2). Significant differences
(R0 vs R1 and Rx) between the SP and non-SP groups were
found at the posterior margin (p = 0.001), the SMA-margin
(p < 0.001) and the SMV-margin (p < 0.001), and in tu-
mours of distal bile duct origin (p = 0.006).
Effect of re-evaluations of slides
The distribution of histopathological characteristics in
the total re-evaluated material, stratified by tumour ori-
gin, is shown in Table 3. In the original reports there
were 14 NSP-cases without information on margin status.
Re-evaluation of slides changed margin status for the
NSP-group, increasing R1 from 45/115 to 60/129 and de-
creasing R0 from 70/115 to 12/129 (p < 0.001), and re-
evaluations also rendered 56 NSP-cases with unknown
margin status (Rx). Re-evaluation of slides rendered a
non-significant increase of R1 in the SP-material, from
63% (29/46) to 76% (35/46) (p = 0.257).
Re-evaluations revealed lymph node involvement in
20% (14/70) of NSP-cases that were N0 in the original
report. This caused a non-significant change in fraction
with involved lymph nodes in the NSP-group, from 46%Table 2 Margin status and tumour origin
Duodenum Ampulla D
NSP SP NSP SP N
9 5 58 12 2
R1, n (%) 1 (11%) 2 (40%) 19 (33%) 5 (42%) 15
R0, n (%) 2 (22%) 3 (60%) 7 (12%) 7 (58%) 3 (
Rx, n (%) 6 (67%) 0 32 (55%) 0 9 (
Pancreas transection margin 0 1 2 0
DBD transection margin 0 0 0 0
SMA margin 0 0 0 0
Posterior surface 0 2 8 4
SMV surface 0 1 0 0
Anterior surface 0 1 1 2
Margin status in 175 re-evaluated pancreaticoduodenectomies. NSP, non-standardiz
mesenteric artery. SMV, superior mesenteric vein. For percentages and significances,
in R1-fraction between the SP-group and the NSP-group were significant in distal bil
margin. R1-cases could have more than one involved margin. Bold text indicates p <(59/129) to 57% (73/129) (p = 0.105). Re-evaluations ren-
dered no alterations in the fraction of involved lymph
nodes in the SP-material.
Overall survival in relation to margin status
Kaplan-Meier analysis revealed a significantly prolonged
five-year OS in the re-evaluated R0-group compared
with the original report R0-group (p < 0.001) (Figure 2).
As further shown in Table 4, the unadjusted HR for R1
vs R0 in the original report was 1.6 (95% CI 1.1 - 2.4). In
the re-evaluated material the unadjusted HR for R1 vs
R0 was 3.3 (95% CI 1.5 - 7.0) and the unadjusted HR for
Rx vs R0 was 2.3 (95% CI 1.0 - 5.2). Re-evaluated, but
not originally reported, margin status remained an inde-
pendent prognostic factor in adjusted analysis (HR 2.2,
95% CI 1.0 - 4.9 for R1 and Rx vs R0) (Table 4). The un-
adjusted and adjusted HRs for re-evaluated histopath-
ology parameters are shown in Table 5.
Discussion
This is, to our best knowledge, the first report on stan-
dardized longitudinal opening and slicing of the com-
mon bile duct in the handling of PD-specimens with
primary adenocarcinoma.
Our results confirm previous reports on standardized
protocols in the pathology examination of operated peri-
ampullary adenocarcinomas by showing that a 1-mm
cut-off in the assessment of margin status is relevant for
overall survival, both in unadjusted analysis and after
adjusting for other histopathology parameters. Micro-
scopic re-evaluation of margin status revealed a larger
proportion of involved margins than stated in the original
reports. Thereby, the prognostic value of uninvolved
margins was increased, regardless of other histopathologyistal Bile Duct Pancreas All tumour origins
SP SP NSP SP NSP SP p-value
7 18 35 11 129 46
(56%) 17 (94%) 25 (71%) 10 (91%) 60 (47%) 34 (74%) 0.002
11%) 1 (6%) 1 (3%) 1 (9%) 13 (10%) 12 (26%)
33%) 0 9 (26%) 0 56 (43%) 0
3 2 9 1 14 (11%) 4 (9%) 0.784
1 1 1 0 2 (2%) 1 (2%) 1.000
2 8 0 2 2 (2%) 10 (22%) <0.001
7 10 7 4 22 (17%) 20 (44%) 0.001
3 10 10 8 13 (10%) 19 (41%) <0.001
4 1 3 2 8 (6%) 6 (13%) 0.202
ed protocol. SP, standardized protocol. DBD, distal bile duct. SMA, superior
calculations were made R0 vs R1 and Rx. In separate tumour origins, differences
e duct origin, (p = 0.006). Some NSP-cases were classified as R1 in an unspecified
0.05.









n = 14 n = 51 n = 19 n = 45 n = 46 n = 175
Standardized Procedure 5 (36%) 7 (14%) 5 (26%) 18 (40%) 11 (24%) 46 (26%)
Age at surgery, M (IQR) 68 (62 – 74) 67 (59 – 70) 69 (62 – 75) 64 (59 – 71) 68 (62 – 72) 67 (61 – 72)
Gender, Female 6 (43%) 29 (57%) 9 (47%) 21 (47%) 21 (46%) 86 (49%)
Tumour size, mm, M (IQR) 40 (30 – 53) 23 (15–30) 30 (24 – 40) 26 (22 – 35) 30 (25 – 35) 30 (21 – 35)
Larger than 20 mm 13 (93%) 27 (53%) 18 (95%) 37 (82%) 39 (85%) 134 (77%)
High grade 7 (50%) 26 (51%) 9 (47%) 31 (69%) 28 (61%) 101 (58%)
Lymph nodes, M (IQR) 10 (6 – 13.5) 9 (6 – 16) 10 (5 – 17) 12 (8 – 16.5) 11.5 (6.75 – 16) 11 (6 – 16)
10 or more lymph nodes 8 (57%) 25 (49%) 10 (53%) 30 (67%) 27 (59%) 100 (57%)
Involved lymph nodes, M (IQR) 0 (0 – 2) 0 (0 – 2) 2 (1 – 7) 1 (0 – 4) 2 (0 – 3) 1 (0 – 3)
pN1 4 (29%) 24 (47%) 16 (84%) 27 (60%) 34 (74%) 106 (61%)
pN2 2 (14%)
Perineural infiltration 4 (29%) 16 (31%) 14 (74%) 37 (82%) 34 (74%) 105 (60%)
Infiltration in lymph vessels 2 (14%) 34 (67%) 15 (79%) 33 (73%) 27 (59%) 111 (63%)
Infiltration in blood vessels 0 (0.0%) 5 (10%) 8 (42%) 14 (31%) 15 (33%) 42 (24%)
Infiltration in peripancreatic fat 6 (43%) 16 (31%) 17 (89%) 36 (80%) 32 (70%) 107 (61%)
T-stage (pTNM)
T1 0 5 (10%) 0 1 (2%) 2 (4%)
T2 1 (7%) 11 (22%) 0 2 (4%) 10 (22%)
T3 6 (43%) 19 (37%) 2 (11%) 42 (93%) 34 (74%)
T4 7 (50%) 16 (31%) 17 (89%) 0 0
R1 3 (38%) 10 (43%) 14 (93%) 32 (89%) 35 (95%) 94 (79%)
R0 5 (63%) 13 (57%) 1 (7%) 4 (11%) 2 (6%) 25 (21%)
Rx,uncertain margin status (n) 6 28 4 9 9 56
Pancreatic transection margin 1 (13%) 1 (4%) 1 (7%) 5 (14%) 10 (27%) 18 (15%)
DBD transection margin 0 0 0 2 (6%) 1 (3%) 3 (3%)
SMA-margin 0 0 0 10 (28%) 2 (5%) 12 (10%)
Posterior margin 2 (25%) 6 (26%) 6 (40%) 17 (47%) 11 (30%) 42 (35%)
SMV-margin 1 (13%) 0 0 13 (36%) 18 (49%) 32 (27%)
Anterior margin 1 (13%) 1 (4%) 2 (13%) 5 (14%) 5 (14%) 14 (12%)
5-year OS, M (IQR), months n.r. (37 - n.r.) 53 (26 - n.r.) 26 (15–40) 25 (16 - n.r.) 25 (13–42) 30 (17-n.r.)
M, median. IQR, interquartile range. OS, overall survival. N.r., not reached.
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nocent”-approach towards margins in pancreaticoduode-
nectomies gives more accurate prognostic information
than the opposite approach. Moreover, survival in the
large group of cases with unassessable margin status (Rx)
differed significantly both from cases with uninvolved
margins and from cases with involved margins, suggest-
ing that it is not appropriate to classify these cases as R0.
The more frequent finding of growth in peripancreatic
fat and perineural tumour growth in SP-cases compared to
NSP-cases may be an effect of more extensive sampling inthe periphery of the tumour as well as along the bile duct
and margins in SP-cases compared with NSP-cases.
Tumour infiltration in blood vessels was more often
found in NSP-cases than in SP-cases (29% vs 9%), which
may be due to an unintended more thorough search for
evaluable pathology parameters in SP-cases that had very
little coverage on margins and lymph nodes. This model
of explanation suggests that the proportion of cases with
tumour infiltration in blood vessels in the NSP-group
more accurately reflects the actual percentage of in-
filtration in blood vessels. As a cautionary remark, the
Figure 2 Kaplan-Meier estimates of five-year overall survival in relation to margin status before and after re-evaluation. Five-year OS in
relation to (A) margin status stated in the original reports and (B) margin status upon re-evaluation of slides.
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of significant differences between the NSP-group and
the SP-group, should also be considered, since a large
number of comparisons have been performed. A type II
error, i.e. failure to detect the true incidence of involved
blood vessels in the SP-group, is also possible due to
the relatively small sample size in this group.
Comparisons of the incidence of involved margins be-
tween our SP-material, excluding duodenal origin, and
other standardized series show 78% R1 (32/41) in our SP-
group compared with 59% (32/54) and 61% (51/83) in the
LEEPP-series [2,3]. The incidence of involved margins is
often not comparable between SP-series and NSP-series,Table 4 Five year overall survival in relation to margin status







R0 90 36.3 (23.1 - n.r.)
Rx
R1 69 25.1 (14.0 - 46.3) 1.6 (1.1 - 2.4) 1.0 (0.7 - 1.6)
Hazard ratios (HR) for risk of death within 5 years in relation to margin status, with
in the original report R0-group (p < 0.001). Differences in OS between the three l
(p < 0.001), R1 vs Rx (p = 0.005) and R0 vs Rx (p = 0.043). HR for both original rep
R0, uninvolved margins. Rx, uncertain margin status. R1, cancer less than 1 mm fromdue to a 0-mm definition of margin involvement, or lack
of definitions on margin involvement in NSP-series. The
fraction of cases with involved lymph nodes is however
comparable, showing that non-standardized series [4-10]
report involved lymph nodes in less than 60% of cases,
compared to more than 70% in our SP-group and in the
LEEPP-series. If such differences are coincidental or actu-
ally statistically significant, as well as their potential clin-
ical significance, remains unknown. In the present study,
we were able to demonstrate a significantly higher num-
ber of involved lymph nodes in the specimens in the SP-
group compared with the NSP-group, despite a temporal
association between an increased number of lymph nodesin the original reports and after re-evaluation







25 n.r. (35.0 - n.r.)
54 40.2 (24.0 - n.r.) 2.3 (1.0 - 5.2) 2.2 (1.0 - 4.9)
93 25.4 (14.6 - 41.6) 3.3 (1.5 - 7.0)
R0 as reference. OS in the re-evaluated R0-group was significantly better than
evels of margin status in the re-evaluated material were significant; R0 vs R1
ort and re-evaluated margin status adjusted for re-evaluated parameters.
margin. IQR, interquartile range. CI, confidence interval. N.r., not reached.
Table 5 Unadjusted and adjusted hazard ratios for death within 5 years in relation to re-evaluated histopathology
parameters
n (events) Unadjusted HR (95% CI) p-value Adjusted HR (95% CI) p-value
Age, continuous 172 (112) 1.0 (1.0-1.0) 0.479 1.0 (1.0-1.1) 0.015
Sex
Female 86 (47)
Male 86 (65) 1.5 (1.0-2.2) 0.042 1.4 (0.9-2.0) 0.131
T-stage
T1 8 (3)
T2 23 (12) 1.5 (0.4-5.2) 0.553 1.1 (0.3-4.4) 0.847
T3 102 (66) 2.7 (0.8-8.6) 0.995 1.0 (0.3-3.8) 0.948
T4 39 (31) 3.4 (1.0-11.2) 0.043 1.3 (0.3-5.1) 0.683
N-stage
N0 67 (37)
N1-N2 105 (75) 2.0 (1.3-2.9) 0.001 1.3 (0.8-2.0) 0.265
Tumour size, continuous 172 (112) 1.0 (1.0-1.0) 0.010 1.0 (1.0-1.0) 0.533
Tumour differentiation
Well-moderate 73 (38)
Poor 99 (74) 2.3 (1.5-3.3) <0.001 1.9 (1.2-2.8) 0.002
Tumour morphology
Intestinal type 63 (31)
Pancreatobiliary type 109 (81) 2.3 (1.5-3.4) <0.001 1.3 (0.7-2.3) 0.394
Margins
R0 25 (7)
R1-Rx 147 (105) 3.3 (1.5-7.0) 0.002 2.2 (1.0-4.9) 0.046
Perineural growth
No 68 (33)
Yes 104 (79) 2.4 (1.6-3.7) <0.001 1.1 (0.6-1.8) 0.779
Growth in lymphatic vessels
No 63 (30)
Yes 109 (82) 2.2 (1.4-3.3) <0.001 1.2 (0.8-1.9) 0.420
Growth in blood vessels
No 131 (74)
Yes 41 (38) 3.1 (2.1-4.7) <0.001 2.4 (1.6-3.7) <0.001
Growth in peripancreatic fat
No 67 (30)
Yes 105 (82) 2.8 (1.8-4.3) <0.001 2.1 (1.4-3.3) 0.001
HR, hazard ratio. CI, confidence interval. Bold text indicates p < 0.05.
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studied standardized protocol.
In our material the differences in tumour origin be-
tween the SP-group and the NSP-group were significant.
It is however not known if there are any clinically rele-
vant differences between the tumour origins of stan-
dardized and non-standardized series. It has however
previous been shown that the morphological distinction
between intestinal and pancreatobiliary morphology hasprognostic implications, not only in ampullary adeno-
carcinomas, but in all periampullary adenocarcinomas, re-
gardless of tumour origin [14]. Moreover, while differences
in the expression of cytokeratins and mucins according to
morphology have been observed in ampullary carcinomas
[15], these differences seem to be less evident in series
stratified solely by the anatomical centre of the ampullary
adenocarcinomas [16]. These findings suggest that mor-
phological and molecular tumour characteristics have a
Elebro and Jirström Diagnostic Pathology 2014, 9:80 Page 10 of 10
http://www.diagnosticpathology.org/content/9/1/80greater prognostic impact than the appreciated tumour
origin.
Despite a very different approach to the specimen, the
results on tumour origin, N-stage and margin status in
our standardized group are similar to the results of the
LEEPP-series [2,3] and to a lesser degree similar to the
results of two other variants on standardized protocols
[17,18]. Whether or not our standardized protocol was
more time consuming or more demanding than the LEEPP,
and thus inferior due to practical reasons, has however not
been studied.
Conclusions
A 1-mm threshold for margin involvement is relevant
for overall survival in operated periampullary adenocar-
cinomas, regardless of tumour origin and other histopath-
ology parameters. Standardized protocols on sectioning
of pancreaticoduodenectomy specimens seem to increase
the yield of adverse prognostic histopathology parameters
compared with non-standardized protocols. Standardiza-
tions in pancreatic pathology are needed to decrease
unjustifiable variability in pathology reports, both for
the sake of the treatment of individual patients and for the
sake of future studies and clinical trials.
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